Benjamin F. Edwards & Company’s Recursion Pharmaceuticals RXRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$1.27M Buy
169,900
+167,302
+6,440% +$1.25M 0.02% 465
2024
Q1
$26K Buy
+2,598
New +$26K ﹤0.01% 1468